Meningococcal Group B Vaccine 2024-2025 (2026, 2027)
Awarded
The competition has ended and a winner has been selected.
Farmasøytisk engroshandel
The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) requested tenders for Meningococcal Group B Vaccine belonging to the National Vaccination Programme in Finland.
Result
- Winner
- GlaxoSmithKline Oy
- Number of bids
- 1
- Contract value
- €300,000
About the bid
- Contact email
- emma.e.korhonen@thl.fi
- Address
- P.O. BOX 33, 00023 Helsinki
The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) requested tenders for Meningococcal Group B Vaccine belonging to the National Vaccination Programme in Finland.
Custom Assessment Criteria
Start a free trial to ask your own questions about the tender and get AI-generated answers.
Award Criteria
Found no award criteria in the contract notice.
Qualification requirements
Found no qualification requirements in the contract notice.
Previous Contract Winners
Start a free trial to see who has won similar tenders for this buyer.
See the full notice
- Contracting authority
- Ministry of Social Affairs and Health
- Title
- Meningococcal Group B Vaccine 2024-2025 (2026, 2027)
- Type
- Main code
- Supplemental codes